Skip to main content
Premium Trial:

Request an Annual Quote

UPDATE: IGC, NCH Awarded Nearly $80M for TCGA Support

This article replaces an earlier version that reported funding solely for IGC.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The International Genomics Consortium (IGC) in Phoenix, Ariz., and the Research Institute at Nationwide Children's Hospital (NCH) in Columbus, Ohio, have been awarded stimulus grants from the National Institutes of Health totaling nearly $80 million over five years to support the Cancer Genome Atlas Program.

IGC and NCH will manage biospecimens and samples for TCGA, as well as provide support services to the National Cancer Institute for researchers involved in TCGA.

The awards, which are funded in part by the American Recovery and Reinvestment Act, will be spread over five years and will provide IGC up to $37.5 million and NCH up to $41.4 million, if the option to extend is exercised after the base period of 18 months. For the base period, IGC will receive $12.3 million and NCH will receive $11.5 million.

IGC and NCH will provide support services for TCGA by establishing Biospecimen Core Resources (BCRs) for receiving tissue and data from the multiple Tissue Source Site networks. They will provide storage, quality control, processing, and shipping of analytes to genome characterization and sequencing centers for TCGA.

The biospecimen core centers' tasks include being an interface between TCGA and tissue source sites; ensuring and verifying that TCGA subject guidelines and protections have been followed; ensuring that all biospecimens meet standards; collecting clinical information about patients and their cancer samples; extracting and distributing DNA and RNA analytes from tissue samples and sending them to sequencing and characterization centers; and contributing to the leadership of the overall TCGA project.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.